Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis

the IXORA-Q Study Group

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint Dive into the research topics of 'Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis'. Together they form a unique fingerprint.

Medicine & Life Sciences